Press Release
Manitoba Woman Beats Stage 4 Cancer with Breakthrough CAR T-Cell Therapy
–News Direct–
Disseminated on behalf of CERo Therapeutics Holdings, Inc.
Cancer treatments have come a long way over the years, but there is a newer treatment that is providing even stage four cancer patients with a new lease on life.
The first CAR T-cell therapy was only approved in 2017, but its already having a significant impact in the cancer treatment market. The latest success story comes from Sandra Hajlo, who just became the first person in Manitoba to be declared cancer-free following CAR T-cell therapy.1
Initially diagnosed with stage four B-cell lymphoma in 2015, Hajlo underwent successful chemotherapy. However, eight years later, her cancer returned, leading to another battle with the disease. After a misdiagnosis of scoliosis, a CT scan revealed her cancer had come back.
Her oncologist recommended CAR T-cell therapy, a new treatment where T-cells are modified to target cancer cells, making her the first recipient of this therapy at CancerCare Manitoba.
Dr. David Szwajcer, Manitoba Blood & Marrow Transplant Director at CancerCare Manitoba, explained that the CAR T-cells are collected, sent to a U.S. facility for modification, and then reintroduced to the patient. Hajlo described the procedure as quick and straightforward, taking only 20 minutes.
After undergoing CAR T-cell therapy in December 2023, Hajlo learned in April 2024 that the treatment was successful, and she is cancer-free once again, expressing her gratitude for the second chance at life.
CAR T-cell therapy does not guarantee survival, with about half of the patients not responding,but it has shown promising results in many cases.
CERo Therapeutics Holdings (NASDAQ:CERO) is an innovative immunotherapy company seeking to advance the next generation of engineered T cell therapeutics. CERo Therapeutics is unrelated to CancerCare Manitoba and had no role in the CAR T-cell therapy described above. Nevertheless, CERo Therapeutics believes that the success of the CAR T-cell therapy in Manitoba may provide an indication of the potential for its proprietary CER-T (chimeric engulfment receptor) cell therapy.
CAR-T cell treatment has a steep price tag and some potential serious side effects including secondary cancer developing2 as well as cytokine release syndrome (CRS),3 which causes your immune system to go into overdrive and is potentially life threatening. CER-T cell therapy may provide a more cost-effective alternative with fewer side effects.
CERo Advances Innovative Cancer Immunotherapy
CERo Therapeutics (NASDAQ:CERO) developed CER-T cells to enhance efficiency and reduce side effects compared to traditional therapies by leveraging the body's natural tumor-fighting mechanisms. CER-T cells achieve this through direct tumor killing and by amplifying the body's anti-tumor immune response, and additionally by presenting cancer cell fragments to other immune cells, drawing these cells to attack the tumor.
Peer-reviewed data shows that CER-T cells have at least eight anticancer functions, offering potent, durable, and low-toxicity therapeutic benefits, with the capability to completely eliminate tumors. The company has validated these findings in 10 animal experiments, including a study on Acute Myeloid Leukemia (AML) published in March 2024.
CERo Therapeutics believes CER-T cells offer greater therapeutic potential than currently approved chimeric antigen receptor (CAR-T) cell therapy, potentially targeting both hematological malignancies and solid tumors. The company plans to begin clinical trials for its lead product candidate, CER-1236, in 2024 for treating hematological malignancies.
CERo has been diligently completing pre-clinical studies and documentation necessary to initiate clinical trials after gaining approval from the FDA for its Investigational New Drug (IND) Application.
CERo Therapeutics Holdings, Inc., (NASDAQ:CERO) has successfully completed toxicity studies for CER-1236, a critical step before applying to the FDA for approval to begin human trials. With these studies showing that CER-1236 can be safely administered, the company is now focusing on ensuring safe manufacturing and finalizing its FDA application. Upon FDA acceptance, the company would be able to commence Phase 1 clinical trials, marking the start of the journey toward US approval and addressing unmet medical needs.
CERo plans to update shareholders on their progress, including presentations at investor conferences, potential growth of their intellectual property portfolio, and advancements in other programs beyond AML.
Click here for more information CERo Therapeutics Holdings, Inc., (NASDAQ:CERO).
Footnotes:
[1] https://globalnews.ca/news/10428035/manitobas-first-car-t-cell-therapy-patient-declared-cancer-free/
[2] https://jamanetwork.com/journals/jama/article-abstract/2815500
[3] https://www.pennmedicine.org/cancer/navigating-cancer-care/treatment-types/immunotherapy/what-is-car-t-therapy
Disclosure:
1) The author of the Article, or members of the authors immediate household or family, do not own any securities of the companies outlined in this Article. The author determined which companies would be included in this article based on research and understanding of the sector.
2) The Article was issued on behalf of and sponsored by, CERo Therapeutics Holdings, Inc. Market Jar Media Inc. was paid $1,500 USD for the production and publishing of this article by CERo Therapeutics Holdings, Inc.s Digital Marketing Agency of Record (Native Ads Inc.). Additional details relating to Market Jar Media Inc.s engagement by CERo Therapeutics Holdings, Inc.s Digital Marketing Agency of Record (Native Ads Inc.) are set out in https://pressreach.com/disclaimer-cero.
3) Statements and opinions expressed are the opinions of the author and not Market Jar Media Inc., its directors or officers. The author is wholly responsible for the validity of the statements. The author was not paid by Market Jar Media Inc. for this Article. Market Jar Media Inc. was not paid by the author to publish or syndicate this Article. Market Jar has not independently verified or otherwise investigated all such information. None of Market Jar or any of their respective affiliates, guarantee the accuracy or completeness of any such information. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security. Market Jar Media Inc. requires contributing authors to disclose any shareholdings in, or economic relationships with, companies that they write about. Market Jar Media Inc. relies upon the authors to accurately provide this information and Market Jar Media Inc. has no means of verifying its accuracy.
4) The Article does not constitute investment advice. All investments carry risk and each reader is encouraged to consult with his or her individual financial professional. Any action a reader takes as a result of the information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Market Jar Media Inc.'s terms of use and full legal disclaimer as set forth here. This Article is not a solicitation for investment. Market Jar Media Inc. does not render general or specific investment advice and the information on PressReach.com should not be considered a recommendation to buy or sell any security. Market Jar Media Inc. does not endorse or recommend the business, products, services or securities of any company mentioned on PressReach.com.
5) Market Jar Media Inc. and its respective directors, officers and employees hold no shares for any company mentioned in the Article.
6) This communication contains statements that are forward-looking and as such are not historical facts. This includes, without limitation, statements regarding the financial position, business strategy and the plans and objectives of management for future operations of CERo. These statements constitute projections, forecasts and forward-looking statements, and are not guarantees of performance. Such statements can be identified by the fact that they do not relate strictly to historical or current facts. When used in this communication, words such as anticipate, believe, continue, could, estimate, expect, intend, may, might, plan, possible, potential, predict, project, should, strive, would and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. When CERo discusses its strategies or plans, it is making projections, forecasts or forward-looking statements. Such statements are based on the beliefs of, as well as assumptions made by and information currently available to, CERos management. Actual results could differ from those implied by the forward-looking statements in this communication. Certain risks that could cause actual results to differ are set forth in CERos filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K, filed on April 2, 2024, and the documents incorporated by reference therein. The risks described in CERos filings with the Securities and Exchange Commission are not exhaustive. New risk factors emerge from time to time and it is not possible to predict all such risk factors, nor can CERo assess the impact of all such risk factors on its business, or the extent to which any factor or combination of factors may cause actual results to differ materially from those contained in any forward-looking statements. Forward-looking statements are not guarantees of performance. You should not put undue reliance on these statements, which speak only as of the date hereof. All forward-looking statements made by CERo or persons acting on its behalf are expressly qualified in their entirety by the foregoing cautionary statements. CERo undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
7) Any graphs, tables or other information demonstrating the historical performance or current or historical attributes of CERo Therapeutics Holdings, Inc. or any other entity contained in this document are intended only to illustrate historical performance or current or historical attributes of CERo Therapeutics Holdings, Inc. or such entities and are not necessarily indicative of future performance of CERo Therapeutics Holdings, Inc. or such entities.
8) Investing is risky. The information provided in this article should not be considered as a substitute for professional financial consultation. Users should be aware that investing in any form carries inherent risks, and as such, there is a possibility of losing some or all of their investment. The value of investments can fluctuate significantly within a short period, and investors must understand that past performance is not indicative of future results. Additionally, users should exercise caution as transactions involving investments may be irreversible, even in cases of fraud or accidental actions. It is crucial to acknowledge that rapidly evolving laws and technical issues can have adverse effects on the usability, transferability, exchangeability, and value of investments. Furthermore, users must be cognizant of potential security risks associated with their investment activities. Individuals are strongly encouraged to conduct thorough research, seek professional advice, and carefully evaluate their risk tolerance before engaging in any investment endeavors. Market Jar Media Inc. is neither an investment adviser nor a broker-dealer. The information presented on the website is provided for informative purposes only and is not to be treated as a recommendation to make any specific investment. No such information on PressReach.com constitutes advice or a recommendation.
Contact Details
James Young
+1 800-340-9767
Company Website
View source version on newsdirect.com: https://newsdirect.com/news/manitoba-woman-beats-stage-4-cancer-with-breakthrough-car-t-cell-therapy-472550199
MarketJar
COMTEX_453434643/2655/2024-06-06T08:32:55
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
Press Release
SAPSOL Technologies Inc Accelerates Zero-Blind-Spot Security with TraceSecureaiPhase 1 Live AI Threat Engine Arriving 2026
Santa Clara, CA, United States, 17th Jun 2025 – SAPSOL Technologies Inc. today unveiled the next milestones of TraceSecure.ai, its enterprise platform that fuses user-behavior analytics with real-time threat detection across both SAP and non-SAP landscapes. Following a successful Phase 1 rollout that now logs every staff visit to external websites via an encrypted ELK pipeline, the company detailed a six-phase roadmap culminating in an AI-powered predictive engine slated for Q3 2026.
“TraceSecure.ai does more than flag threats, it visualises every step a person or process takes, badge swipe by badge swipe and click by click,” said Sam Mall, CEO of SAPSOL Technologies. “From a refinery control room to a pharmacist’s workstation, we stitch the entire journey into one continuous narrative. Without juggling ten different dashboards. TraceSecure.ai stitches those moments together, applies behavioural AI, and flags anomalies before they become million-dollar incidents.”
Roadmap at a Glance
- Phase 1 — LIVE (Q2 2025): Non-SAP web tracing
- Phase 2 (Q3 2025): SAP Cloud access-attempt monitoring
- Phase 3 (Q4 2025): Identity-resolution & threat scores graphs
- Phase 4 (Q1 2026): Productivity analytics for SAP GUI, Fiori and Windows apps
- Phase 5 (Q2 2026): Unified dashboards—security + efficiency on a single screen
- Phase 6 (Q3 2026): ML-driven anomaly detection, auto-remediation policies
- Beyond (Q4 2026+): Hooks for CCTV, SCADA and SAP SuccessFactors, plus SOX/NERC/GxP audit generators
What TraceSecure.ai Delivers
- Complete User Timelines – Every human and machine identity is mapped in real time across RFID, CCTV, SCADA, SAP, Salesforce, Microsoft 365 and dozens of other sources.
- Behavioural-AI Detection – Machine-learning baselines tuned for each role and industry cut false positives by nearly half in pilot deployments.
- Audit-Ready Evidence – One-click exports satisfy NERC/CIP, FDA 21 CFR Part 11, Sarbanes-Oxley, GDPR and country-specific critical-infrastructure regulations.
- Productivity Heat-Maps – Operations and HR leaders uncover idle-time pockets, workflow bottlenecks and training gaps previously hidden in siloed logs.
- Rapid Time-to-Value – Pre-built connectors and white-glove onboarding compress typical implementation from months to weeks.
Built for Heavy-Regulated Industries
Oil & gas refiners needing NERC-CIP sub-minute alerts, pharma labs governed by FDA 21 CFR 11, retail chains chasing PCI compliance and public-sector agencies under SOX scrutiny all gain pre-configured controls. Mapping to GDPR Art 5, HIPAA §164.312 and NERC-CIP-007 is native out-of-the-box. Check full list at https://www.sapsol.com/industry-verticals/
- Oil & Gas – Field engineers often move from isolated wellheads to central SCADA consoles and back; TraceSecure.ai couples badge data with SAP PM records to spot suspicious sequencing and block credential misuse.
- Utilities – Sub-minute NERC/CIP detection windows are met by overlaying control-room access with breaker commands and network telemetry in a single alert stream.
- Retail – Refund fraud and self-checkout abuse are uncovered when POS overrides, CCTV markers and browsing histories converge in one behaviour profile.
- Pharma / Life Sciences – GMP compliance is simplified as lab door swipes, LIMS edits and ERP batch records align in an immutable chain of custody.
- Public Sector – Zero-trust initiatives gain teeth when hybrid civil-service activity is traced seamlessly across VPN, Microsoft 365 and in-person kiosks.
Under the Hood
- Agents & Sensors: browser_agent.js and pcap_service.py capture URLs, durations and packets at the endpoint layer, while sap_monitor.vbs extracts SAP T-Code usage.
- Streaming Fabric: All events flow through Kafka topics (e.g., sapcloud.access) before landing in Elasticsearch/MongoDB for high-speed search and Graph-based correlation.
- Security Posture: TLS in transit, AES-256 at rest, plus strict RBAC on every index and dashboard.
“Teaming up with SAPSOL to launch TraceSecure.ai marks a pivotal growth milestone for MergedAnalytics. This collaboration seamlessly connects B2B digital engagement intelligence with enterprise operations, delivering real-time insights into both internal and external behavior. By analyzing behavioral patterns, we empower businesses to recognize purchase and support signals—turning engagement into actionable outcomes.” — Joe Singer, Co-founder, MergedAnalytics
Why TraceSecure.ai Stands Apart
- Dual Lens: Combines MES-style time-in-app metrics with SOC-grade threat analytics.
- SAP-Aware: Reads SAP GUI, Fiori, and upcoming BTP traffic—richer context than generic SIEMs.
- Proven Foundation: Phase 1 is already live enterprise-wide, offering a frictionless proof of value.
- Predictive Future: Road-mapped ML models promise autonomous policy enforcement by 2026.
Availability & Next Steps
Phase 2 pilots begin in August 2025. Interested organizations in oil & gas, utilities, retail, pharma or the public sector can request a 14-day, no-cost proof of concept that streams select TraceSecure.ai capabilities into a sandbox landscape. Registration is open at sapsol.com/free-sap-poc
About SAPSOL Technologies Inc.
SAPSOL Technologies Inc. is a North American provider of SAP-centric digital-transformation services, renowned for zero-downtime migrations, cloud security accelerators, and AI-driven automation frameworks. With delivery centres in Canada and consulting teams across the United States, SAPSOL partners with enterprises to modernise mission-critical processes at speed and scale.
About Merged Analytics Inc.
Merged Analytics Inc. converts raw interaction data—clicks, swipes, machine telemetry—into actionable behavioural intelligence. Its patented algorithms power predictive-security and productivity solutions for Fortune 1000 companies and public-sector agencies worldwide.
Media Contacts
Aaron Samuel Philip
Digital marketing, SAPSOL Technologies Inc.
+1 289-4060845 | aaron@sapsol.com
Thom Stallings
Co-Founder, MergedAnalytics LLC
+1 814-826-2046 | tstallings@mergedanalytics.com
Media Contact
Organization: SAPSOL Technologies Inc.
Contact Person: Aaron Samuel Philip
Website: https://tracesecure.ai
Email: Send Email
City: Santa Clara
State: CA
Country:United States
Release id:29248
The post SAPSOL Technologies Inc Accelerates Zero-Blind-Spot Security with TraceSecureaiPhase 1 Live AI Threat Engine Arriving 2026 appeared first on King Newswire. This content is provided by a third-party source.. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
Australia, 17th Jun 2025, – Adept Photo Booths, a leading provider of event-based photo booth experiences in Australia, has expanded its photo booth hire services into Brisbane, strengthening the company’s national capabilities and enhancing service access across Queensland. The move brings a broad range of print and digital booth experiences to the region, tailored to suit corporate events, weddings, private functions, festivals, and public activations.
The expanded services now available in Brisbane include digital options such as the 360 Photo Booth, GLAM Bot, AI Photo Booth, Roaming Booth, GIF Booths, and Video Booths, alongside traditional print formats including Open Booths, Mirror Booths, Vintage Booths, and Mosaic Photo Walls. Interactive installations such as Face Morphing and Green Screen activations have also been integrated into the regional offering.
Colin Richardson, General Manager of Adept Photo Booths, noted that the Brisbane expansion responds to rising demand for interactive and branded experiences across the events sector, “Brisbane has seen continued growth in both the scale and sophistication of events, particularly in the corporate and community spheres,” said Richardson. “This expansion enables greater local access to a full suite of photo booth solutions, supported by dedicated logistics and technical teams within the region.”
With operations already established in major Australian cities including Perth, Melbourne, Sydney, Adelaide, and Hobart, the Brisbane expansion reflects a wider strategy to decentralise service infrastructure and enhance responsiveness to regional clients. The rollout includes local equipment storage, trained technician teams, and strengthened relationships with event venues across south-east Queensland.
Adept Photo Booths’ offering spans both short-term event hire and long-term venue installations. Services are designed to support engagement, digital content creation, and audience interaction at a variety of event types—from large public gatherings and trade shows to intimate celebrations and in-store activations.
Digital booth formats incorporating artificial intelligence, real-time social media sharing, and branded content production are increasingly being used to support marketing and brand engagement strategies. These tools are now more readily accessible to clients in Brisbane due to the improved local presence.
Increased availability of services in the region is expected to reduce transport-related lead times and enable closer coordination between project teams, venues, and event organisers. All activations are delivered by trained professionals and backed by national quality standards.
The company’s focus on user experience, image quality, and customisable content has supported successful collaborations with organisations in sectors including retail, technology, sport, tourism, and education. Each activation is tailored to meet the creative and operational needs of its setting.
In discussing the broader direction of the business, Richardson commented on the importance of continuing to evolve with industry needs and technological developments.
“Ongoing investment in service delivery and regional infrastructure will enable more flexible, sustainable, and immersive event experiences,” Richardson said. “The future of event content creation lies in adaptive formats that deliver high-quality outcomes without increasing complexity for organisers.”
Adept Photo Booths is currently accepting bookings for Brisbane and regional Queensland, with support available through its national service line. Enquiries are welcome for both one-off events and long-term activations.
For media enquiries or further information about Photo Booth Hire Brisbane, please contact Adept Photo Booths on 1300 233 781 or via email at hello@adeptphotobooths.com.au.
Media Contact
Organization: Adept Photo Booths
Contact
Person: Colin Richardson
Website:
https://www.adeptphotobooths.com.au/
Email:
hello@adeptphotobooths.com.au
Contact Number: 61300233781
Address 2: Brisbane QLD
Country:Australia
The post Adept Photo Booths Grows Photo Booth Hire Offerings in Brisbane appeared first on
Brand News 24.
It is provided by a third-party content
provider. Brand News 24 makes no
warranties or representations in connection with it.
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
United States, 17th Jun 2025, – Promax, a manufacturer of precision-engineered pogo pins, spring-loaded connectors, and magnetic connectors, has reaffirmed its position as a trusted supplier to critical sectors including consumer electronics, aerospace, and medical technology. With over 15 years of industry experience, the company continues to deliver connector systems built to meet rigorous technical and regulatory standards.
Headquartered in Gary, Indiana, Promax operates with a focus on technical precision and scalable production capabilities. Its engineering and manufacturing practices have evolved to support increasing global demand for compact and reliable connection solutions. All manufacturing processes are backed by international certifications that reflect conformance to quality and safety protocols recognized across multiple industries.
Promax’s product lines serve a wide range of applications requiring secure and efficient electrical connectivity. From small-scale electronic devices to mission-critical medical and aerospace equipment, the company’s components are selected for their durability, performance stability, and adaptability to specialized use cases.
“The core of the operation remains centered on precision and consistency,” said Gavin, Manager at Promax. “In every sector served, from medical diagnostics to high-altitude aerospace systems, reliability is not optional. The ability to provide connectors that meet strict tolerance and performance demands continues to be the defining element of this company’s role in the supply chain.”
To meet evolving technical requirements, Promax has invested in the development of advanced contact solutions, including refined magnetic connectors and compact spring-loaded contacts. These technologies support modern design trends that emphasize space efficiency, reduced resistance, and integration into smaller, more complex assemblies. Every component undergoes extensive quality testing to ensure it meets defined specifications before entering distribution.
The company’s internal systems include automated inspections and batch validation protocols, which have enabled large-scale fulfillment without compromising consistency. This infrastructure supports long-term supply agreements with manufacturers across North America, Europe, and Asia. Clients span a range of industries that rely on dependable connector functionality under varying mechanical and environmental conditions.
Promax maintains direct coordination with design engineers and technical teams to align component capabilities with device-level specifications. Early engagement in product development stages allows for more accurate adaptation of connector types and ensures manufacturability at scale. By incorporating design-for-manufacture methodologies, lead times and iteration cycles are minimized, resulting in reduced project delays.
The company’s ongoing strategy includes readiness for new application areas such as robotics, electric vehicle subsystems, and next-generation communication hardware. These markets require highly specialized connector systems capable of supporting increased data rates, vibration resistance, and environmental sealing, all within compact footprints.
“Technical demands are shifting rapidly across sectors influenced by automation and miniaturization,” added Gavin. “The long-term operational focus is on supporting this transition with connector solutions engineered to meet emerging requirements for electrical performance, mechanical resilience, and integration flexibility.”
Promax continues to assess future market trends while advancing internal processes to support high-mix, high-reliability manufacturing. The company’s direction remains grounded in compliance, performance validation, and long-term relationships with global equipment manufacturers.
For further information, contact Promax, a connector manufacturing company, at (765) 705-7361, via email at tonyhoo@promaxpogopin.com, or by mail at 480 Jackson St, Gary, IN 46402, USA.
Media Contact
Organization: Promax
Contact
Person: Gavin
Website:
http://promaxpogopin.com/
Email:
tonyhoo@promaxpogopin.com
Contact Number: 17657057361
Address:480 Jackson St
Address 2: Gary, IN 46402
Country:United States
The post Promax Delivers Reliable Solutions as a Trusted Connector Manufacturing Company appeared first on
Brand News 24.
It is provided by a third-party content
provider. Brand News 24 makes no
warranties or representations in connection with it.
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
SAPSOL Technologies Inc Accelerates Zero-Blind-Spot Security with TraceSecureaiPhase 1 Live AI Threat Engine Arriving 2026
Promax Delivers Reliable Solutions as a Trusted Connector Manufacturing Company
Adept Photo Booths Grows Photo Booth Hire Offerings in Brisbane
Bay Smokes Maintains Quality Amid Legislative Changes in the Hemp Industry
Benzinga Money Article Discusses How to Become Part of the 12% of Retirees Who Have Achieved the Recommended $550,000 Minimum Retirement Savings Threshold
Apu Apustaja Conquers New York with Lively Street Ads, Including Times Square Billboard
-
Press Release3 days ago
Dallas Agency Breaks Industry Norms with Risk-Free Reputation Management Trial for Small Businesses
-
Press Release4 days ago
Querv Exchange Upgrades Web Platform with Multilingual and Intelligent Navigation
-
Press Release7 days ago
Dr Yahia Ananes Metabolic Protocol Offers New Integrative Strategy for Chronic Illness and Cancer Support
-
Press Release2 days ago
Coinsult Sets the Standard in Smart Contract Audits With Proven Track Record and Introduces New Dashboard
-
Press Release1 week ago
Driven by RWA and AI, NPC leads the new era of crypto finance
-
Press Release3 days ago
Royal Saints Launches Bold New Streetwear Brand Where Urban Edge Meets Regal Style
-
Press Release3 days ago
Dallas Agency Breaks Industry Norms with Risk-Free Reputation Management Trial for Small Businesses
-
Press Release3 days ago
Investors Abandons Cloud’s Mining as Lithium LLC Dominates Passive Crypto Income Space